Dewpoint Therapeutics’ second development candidate, DPTX3496 is an oral, small molecule acting via a novel ...

A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will respond to new therapies.

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

During and after an exacerbation, mental recovery involves taking care of both your physical and mental health. Resting, ...

Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

BOSTON - Patients with lung nodules often have to undergo several procedures including biopsy and multiple surgeries, but a ...

The WVU Cancer Institute is the first provider in the state to offer a new and promising treatment for extensive-stage small ...

The World Health Organisation (WHO) says that lung cancer is often diagnosed at advanced stages when treatment options are ...